About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Experimental Drug Holds Promise to Reduce Stroke Risk

by VR Sreeraman on September 2, 2009 at 12:35 PM
 Experimental Drug Holds Promise to Reduce Stroke Risk

A new drug developed as an alternative to popular drug warfarin, also used as rat poison, has been found to significantly reduce stroke risk.

Generally, patients at risk of stroke are given warfarin to prevent blood clotting, but the treatment is risky and requires regular monitoring.

Advertisement

In the new study, the doctors found that the new drug, dabigatran (Pradaxa), was 34 per cent more effective at reducing the risk of stroke and blood clots in at-risk patients than well-controlled warfarin.

It also reduced death rates by 15 per cent.

In the three-year long study, the researchers recruited patients with an average age of 71, all of whom suffered from atrial fibrillation, a heart rhythm disorder that greatly increases the risk of stroke.
Advertisement

The British Heart Foundation said that the results for an alternative to warfarin were promising, but the drug would not be available to patients until next year at the earliest.

"Warfarin is a highly effective treatment when indicated for stroke prevention, but it is underused, often because of safety concerns or the need for regular blood tests to monitor its effects," Times Online quoted Keith Muir, a medical advisor for the Stroke Association, as saying.

The trial indicates that dabigatran may offer a useful alternative to warfarin for stroke prevention in some circumstances.

"However, the trial only involved people who could equally well have taken warfarin, and anyone currently taking warfarin should continue it unless advised by their doctor," he added.

The study has been published in the New England Journal of Medicine.

Source: ANI
LIN
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Painkillers With Hormonal Contraception Linked to Blood Clot Risk
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Experimental Drug Holds Promise to Reduce Stroke Risk Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests